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Abstract
Background: Target capture sequencing is an efficient approach to directly identify the causative mutations of
genetic disorders. To apply this strategy to laboratory rats exhibiting various phenotypes, we developed a novel
target capture probe set, TargetEC (target capture for exons and conserved non-coding sequences), which can
identify mutations not only in exonic regions but also in conserved non-coding sequences and thus can detect
regulatory mutations.
Results: TargetEC covers 1,078,129 regions spanning 146.8 Mb of the genome. We applied TargetEC to four inbred
rat strains (WTC/Kyo, WTC-swh/Kyo, PVG/Seac, and KFRS4/Kyo) maintained by the National BioResource Project for
the Rat in Japan, and successfully identified mutations associated with these phenotypes, including one mutation
detected in a conserved non-coding sequence.
Conclusions: The method developed in this study can be used to efficiently identify regulatory mutations, which
cannot be detected using conventional exome sequencing, and will help to deepen our understanding of the
relationships between regulatory mutations and associated phenotypes.
Keywords: Target capture sequencing, Exome, Conserved non-coding sequence, Rat
Background
Whole exome sequencing (WES) is used to sequence
only the exonic portion of the genome, which comprises
1–2 % of the entire genome. Hence, WES reduces the
cost associated with the identification of the causative
mutations of a certain disease while maintaining the effi-
ciency of mutation detection in protein-coding regions
that might substantially affect the phenotype. Since the
use of this method to select an entire set of human
exons for sequencing using probe hybridization [1] and
its first application for the identification of a gene in-
volved in a genetic disease were reported [2], WES has
been successfully applied to the identification of respon-
sible genes and their causative mutations in many dis-
eases (for review, see [3]).
Although WES has been mainly applied to human
genetics, some studies have investigated WES applica-
tion to mouse exome [4, 5], which is among the most
widely used animal models in basic molecular biology
and biomedical science. Rat has also been used exten-
sively as a model for various human diseases and the
genome has been sequenced [6]; however, WES analyses
of rat exome have not yet been reported because of the
lack of a commercially available exome capture kit. It is
possible to design a customized capture kit for the de-
sired target sequences in such species. Some applications
of exome sequencing have been described for some spe-
cies for which commercial capture kits are not available.
These species include dogs [7, 8], pigs [9], cows/bison
[10], chipmunks [11], and non-human primates [12].
In the conventional WES target capture method, all
regions except for exons and their neighboring splice
sites are eliminated as targets. As such, mutations in
most regulatory regions, which often reside in non-
exonic regions, are, in principle, hardly detected despite
the fact that mutations in these regions have been found
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to be responsible for certain diseases such as preaxial
polydactyly [13] and the Pierre Robin sequence [14] (for
review, see [15–18]). Such mutations are often identified
through genome-wide association studies (GWASs). For
example, among the published reports of 2304 studies
(16,831 associations) registered in the GWAS Catalog
(October 30, 2015) [19], the reports of 535 studies (2276
associations) stated that significant markers were found
in intergenic regions distant from any annotated genes.
These may be candidates for disorder- or risk-associated
loci that harbor regulatory mutations, which cannot be
detected using conventional WES as this technique tar-
gets only the exons in protein-coding genes. Because
these regulatory regions are functionally important and
have been subjected to selective pressure, they tend to
be conserved during the course of evolution [20]. There-
fore, to ensure that the target capture procedure covers
not only exons for protein-coding genes but also pos-
sible regions containing regulatory mutations, these re-
gions, namely conserved non-coding sequences (CNSs),
should be included in the target. Advances in vertebrate
genome sequencing and subsequent comparative genomic
analyses have made it possible to decipher such regions
under strong selective constraints. Information about
these regions can easily be retrieved from the multiple
genome sequence alignments provided by the UCSC
Genome Browser [21].
One key step in a WES data analysis is the filtering of
known single nucleotide variants (SNVs) that are com-
monly observed in different individuals and hence thought
not to be associated with a certain phenotype of interest.
At this stage, filtering efficiency depends on the number
of known SNVs commonly found in wild-type samples.
The most popular data repository for these variants is
dbSNP [22]. The number of rat SNVs in dbSNP (Build
146; November 24, 2015) is approximately 5.1 million,
whereas 150.5 million and 99.5 million variants are reg-
istered for the human and mouse, respectively. This
discrepancy has been considered a disadvantage with
regard to rat exome analysis in comparison to human
and mouse analyses. Fortunately, rapid progress in gen-
ome sequencing and the identification of sequence vari-
ations in several rat strains have recently been made
[23–26]. These resources concerning sequence varia-
tions in rat will allow an efficient focus on variants that
might be responsible for a certain phenotype.
Here, we describe the development of a novel rat tar-
get capture probe set, TargetEC (target capture for exons
and CNSs). This probe set covers not only the annotated
exons for protein-coding genes but also CNSs, and thus
allows the detection of variations in genomic regions im-
portant for regulatory functions. To evaluate its perform-
ance, we applied the TargetEC to two normal rat strains,
WTC/Kyo and PVG/Seac. In addition, as a proof of
concept, we also applied this probe set to two mutant rat
strains to demonstrate its ability to identify causative mu-
tations for the phenotypes: WTC-swh/Kyo, which exhibits
a sparse and wavy hair (swh) phenotype [27], and KFRS4/
Kyo, which exhibits multiple phenotypes such as congeni-
tal cataract formation [28] and ear malformation [29].
This study describes a powerful method by which to iden-
tify the causative mutations of various phenotypes in rat
strains.
Results
Design of target capture regions for sequencing
RefSeq [30] and Ensembl [31] were used for gene anno-
tation; these databases contain 18,573 transcripts for
17,168 genes with coverage of 39.0 Mb of the genome,
and 30,404 transcripts for 26,689 genes with coverage of
48.2 Mb of the genome, respectively. By merging these
two gene annotations, the genomic regions covered by
these annotations increased slightly to 50.8 Mb.
Many regions in the genome sequences of vertebrate
species exhibit a very high level of conservation, suggest-
ing that selective pressure has acted on these regions to
ensure certain functions (Fig. 1). These regions are com-
prised of not only exons, but also CNSs. A certain fraction
of CNSs might correspond to regulatory elements for
gene expression, which are not well annotated even in
the human and mouse genomes. By including these re-
gions in target capture sequencing, it might be possible
to identify regulatory mutations that would not be tar-
gets of conventional exome sequencing. In this study,
we used phastCons scores [21], which range from 0.0
(low conservation) to 1.0 (high conservation) and were
calculated for the genome alignment of 13 vertebrate
species (including rat as the reference genome) as an
index for genome sequence conservation. We focused
only on highly conserved regions with phastCons scores
of 1.0, which accounted for 36.1 Mb of the rat genome; of
these, 5.4 Mb did not overlap with exons. Here we must
note that when designing capture probes, shorter regions
must be expanded to at least 100 bp to ensure efficient
target region capture. Because non-exonic conserved re-
gions (median: 5 bp) tend to be shorter than exonic re-
gions (median: 132 bp for RefSeq exons), the inclusion of
non-exonic conserved regions drastically affects the total
lengths of the capture probes. Mainly for this reason, we
focused only on regions with phastCons scores of 1.0 for
CNS capture. By merging these regions (i.e., exons and
CNSs) and expanding the minimum length of the re-
gions to 100 bp, we obtained initial target regions
(588,195 regions, total = 137.9 Mb). After optimizing the
probe design using the manufacturer’s internal protocols,
we finally obtained target regions for TargetEC (1,078,129
regions, total = 146.8 Mb) that were subsequently applied
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to capture probe design using the SeqCap EZ Developer
Library product from Roche NimbleGen.
By including CNSs in our target regions, the target
density on the genome is much higher than the density
achieved with conventional exome sequencing. In other
words, the target capture kit can be used not only to de-
tect SNVs and small INDELs within the target regions,
but also to identify large deletions that contain target re-
gions. To quantitatively assess the ability to detect large
deletions using TargetEC, we measured the proportion
of genomic regions in which large deletions of various
lengths could be detected using the TargetEC probes,
and compared the result with that of a hypothetically de-
signed conventional exome probe that only targets ex-
onic regions (Fig. 2). The probe intervals in TargetEC
suggest that a 100-kb genomic deletion could be de-
tected in 93.4 % of the entire genome, whereas this value
decreased to 57.7 % using the conventional exome de-
sign. Similarly, a 10-kb genomic deletion could be de-
tected in 63.8 % of the entire genome with TargetEC,
whereas this value decreased to 24.1 % of the genome
using the conventional exome design. We also measured
the proportion of the CNSs that are located close vicin-
ity to annotated exons. Those CNSs might be sequenced
even by conventional exome design because of the insert
size of the library in exome experiments (typically around
250 bp). We found that only 6.1 % of CNSs (41,393 out of
677,605 CNS regions) are located within 250 bp to the
closest exons. This means that about 90 % of CNSs can
not be covered by conventional exome design.
Target capture sequencing
To evaluate the performance of TargetEC, we applied
this probe set to four rat inbred strains (WTC/Kyo,
WTC-swh/Kyo, PVG/Seac, and KFRS4/Kyo) maintained by
the National BioResource Project for the Rat (NBRP-Rat)
in Japan [32], followed by sequencing using an Illumina
HiSeq 1500 with 2 × 101-bp or 2 × 251-bp paired-end se-
quencing (Table 1). The obtained reads have been deposited
in a public database (DDBJ Sequence Read Archive acces-
sion number: DRA004543). WTC/Kyo and PVG/Seac were













Fig. 1 A genome browser view illustrating genome sequence conservation around Cyp26a1. The track at the top indicates the structure of Cyp26a1,
followed by the phastCons conservation score track calculated for the genome alignment of 13 vertebrate species. The last two tracks represent the

































Fig. 2 Proportion of genomic regions that can detect various deletion
lengths. Two probe sets, TargetEC (green) and a subset of probes that
correspond to exonic regions (blue), are used. a Deletion size up to
400 kb. b Zoom view to show detailed differences in deletion sizes up
to 20 kb
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respectively, both of the mutant strains exhibit promin-
ent phenotypes (for details, see NBRP-Rat homepage:
http://www.anim.med.kyoto-u.ac.jp/nbr/). The total num-
bers of bases obtained just after sequencing ranged from
33.2 Gb (PVG/Seac) to 37.6 Gb (WTC-swh/Kyo). These
reads were mapped onto the rat genome (rn5; March
2012), and more than 99.1 % of the bases appeared to be
mapped in all four samples. After removing duplicated
reads, 85.2–94.2 % of the initially-obtained reads were
retained as final mapped reads. Of these reads, more than
78.3 % of the initially-obtained reads were mapped onto
target regions. Because we obtained a rather high number
of reads, the average depth of coverage in the target re-
gions ranged from 108.0 (WTC-swh/Kyo) to 125.3
(KFRS4/Kyo). In all four samples, more than 99 % of
the target regions were covered with a depth of ≥10.
We constructed plots to analyze the relationship be-
tween the depth of coverage and the target regions cov-
ered with a certain minimum depth (Additional file 1:
Figure S1). For WTC/Kyo, 84.4 % of the target regions
were covered by at least 50 reads, and 97.9 % by at least
20 reads. The coverage trends for the remaining three
strains were very similar (Additional file 1: Figure S1).
Here, we have to note that the median values of the insert
size of the library range from 205 to 214 bp. This means
that significant fraction of pairs of reads overlap with each
other especially for the samples sequenced with the read
length of 251 bp. We also measured the proportion of the
target regions that was not covered by any reads in each
of the four strains. This ranged from 0.15 to 0.17 %. The
proportion of the target regions that are not covered by
any reads in all four strains was only 0.067 %.
According to the molecular phylogenetic trees of in-
bred laboratory rat strains constructed using microsatel-
lite markers [33] and SNPs [23], WTC/Kyo, PVG/Seac,
and the reference strain BN/SsNHsdMCW are widely
separated on the tree, indicating a divergence in genomic
sequences among these strains. Indeed, the polymorphic
rate, measured by microsatellite markers, between WTC
and BN/SsNHsdMCW was close to the highest value
[33]. In spite of this divergence, the sequence reads of all
strains analyzed in this study mapped well on the ref-
erence strain, BN/SsNHsdMCW. This indicates that
although the probe sequences were designed based on
the BN/SsNHsdMCW reference strain, TargetEC can
be applied to a wide range of commonly-used inbred
laboratory rat strains for the systematic identification
of mutations in regions with functional importance
(i.e., exons and CNSs).
Variant identification
We next applied variant calling procedures to mapped
reads for SNV and INDEL identification (Table 2). Here
we only considered mutations identified in target regions
with a coverage depth of ≥10. In all groups of regions
(i.e., CDS, UTR, and CNS), the numbers of SNVs and
INDELs were higher in WTC/Kyo and WTC-swh/Kyo
than in PVG/Seac and KFRS4/Kyo, which was derived as
a congenic strain using PVG/Seac as an inbred partner
strain. This finding indicates a higher level of genetic di-
vergence in BN/SsNHsdMCW vs. WTC/Kyo than in
BN/SsNHsdMCW vs. PVG/Seac. This result is consistent
with the genomic differences measured using polymor-
phisms determined by 357 microsatellite markers, in which
the rates of polymorphic markers in BN/SsNHsdMCW vs.
WTC/Kyo and in BN/SsNHsdMCW vs. PVG/Seac were
89 and 85 %, respectively [33]. We also compared the
SNVs identified in WTC/Kyo and PVG/Seac (Fig. 3a). We
omitted the other two strains from this analysis as each
was similar to either of the analyzed strains. We found that
54.4 % of SNVs in WTC/Kyo and 60.8 % of those in PVG/
Seac were common between WTC/Kyo and PVG/Seac.
The ratios of common SNVs in each group of regions (i.e.,
CDS, UTR, CNS, and other regions) were highly similar to
those among the total identified SNVs (Additional file 1:
Figure S2). The transition/transversion (Ti/Tv) ratio ranged
from 3.56 to 3.66 in CDS, whereas the ranges for UTR and
CNS were smaller (2.43–2.48 and 2.30–2.37, respectively).
These values are consistent with previous reports [34]. The
higher Ti/Tv ratio in CDS might be mainly attributed to
codon degeneracy, i.e., the third position of a two-fold
degenerate codon is always purine (A/G) or pyrimidine
(C/T). We also calculated the numbers of mutations in
various coverage depths (Additional file 1: Table S1).
We also measured a proportion of the SNVs in terms
of each target region class: CDS, UTR, CNS, and others
(Fig. 3b and Additional file 1: Figure S3). Although we
designed our capture kit to cover only exonic regions
and CNSs (phastCons score = 1.0), it also covered some
flanking regions because of the expansion to a minimum
Table 1 Summary statistics for sequencing and mapping
Strain Total reads Read
length
Mapped reads (%) After removing duplicated
reads (%)
Reads on target (%) Average target
depth
% target with coverage
depth of ≥10×
WTC/Kyo 149,260,414 251 149,076,094 (99.9) 140,578,240 (94.2) 117,852,971 (79.0) 108.0 99.3
WTC-swh/Kyo 149,679,520 251 149,510,020 (99.9) 140,569,239 (93.9) 118,321,570 (79.0) 107.6 99.3
PVG/Seac 328,315,192 101 325,289,595 (99.1) 279,768,743 (85.2) 257,155,712 (78.3) 120.4 99.4
KFRS4/Kyo 335,799,700 101 333,078,486 (99.2) 289,224,244 (86.1) 264,672,454 (78.8) 125.3 99.4
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length of 100 bp and optimization of hybridization using
the manufacturer’s internal protocols. Accordingly, ap-
proximately 60 % of the residues in the target could not
be classified as CDS, UTR, or CNS. In Fig. 3b, we present
our results for the WTC/Kyo strain, but note that the re-
sults for the other three strains were almost identical
(Additional file 1: Figure S3). Our findings clearly indicate
that mutations are highly suppressed among CNSs and
CDSs, whereas fewer constraints are placed on UTR; in
contrast, the remaining regions are relatively susceptible
to mutations.
To further analyze the relationship between the muta-
tion frequencies and selective pressure acting on each
genomic region, we plotted SNV density as a function
of the phastCons score (Fig. 3c and Additional file 1:
Figure S4). As expected, we observed a clear negative
correlation between the SNV density and phastCons
score. Although phastCons scores are calculated for
genome alignments of vertebrate species, which include
not only mammals but also chicken and zebrafish, the
existence of a negative correlation between the SNV
density and phastCons score indicates a similar trend
of selective pressure among different strains of rats.
Validation of TargetEC for the identification of known
causative mutations
To validate whether our approach could detect the causa-
tive mutations of certain phenotypes, we analyzed muta-
tions identified by TargetEC in the WTC-swh/Kyo and
KRFS4/Kyo strains. For each of these strains, we used
WTC/Kyo and PVG/Seac, respectively, as control strains.
WTC-swh/Kyo is a rat model of hypohidrotic ectoder-
mal dysplasia (HED) [35]. HED is known to be caused
by mutations in genes encoding proteins involved in the
Eda pathway, which include ectodysplasin (Eda), the ED
receptor (Edar), and EDAR-associated death domain
(Edaradd) [36]. In the case of WTC-swh/Kyo, previous
linkage analysis revealed that the causative mutation
Table 2 Summary statistics for SNV and INDEL
Strain SNV INDEL
Totala (Ti/Tv) CDS (Ti/Tv) UTR (Ti/Tv) CNS (Ti/Tv) Totala CDS UTR CNS
WTC/Kyo 152,047 (2.43) 14,943 (3.61) 12,932 (2.46) 10,816 (2.31) 28,915 775 2,744 3,101
WTC-swh/Kyo 151,981 (2.42) 14,942 (3.61) 12,953 (2.45) 10,824 (2.30) 28,870 753 2,727 3,124
PVG/Seac 135,979 (2.43) 13,554 (3.56) 11,778 (2.48) 9,494 (2.36) 25,876 719 2,538 2,737
KFRS4/Kyo 134,604 (2.43) 13,266 (3.66) 11,466 (2.43) 9,489 (2.37) 25,578 677 2,439 2,759
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Fig. 3 Variants identified by TargetEC. a Numbers of homozygous SNVs identified in the WTC/Kyo and PVG/Seac strains. Only SNVs in regions
with a coverage depth of ≥10 were used. b Proportions of the number of SNVs in each class of target regions in the WTC/Kyo strain: CDS, UTR,
CNS, and others. The proportions are compared with the region lengths. c The relationship between the phastCons conservation score and SNV
density in the WTC/Kyo strain. SNV density was calculated as the number of SNVs divided by the lengths of regions with a certain phastCons
score range (binned for every 0.05 interval)
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resides in the distal end of rat chromosome 17 [27].
More recently, the locus was identified within a 161-kb
interval between the microsatellite marker D17Rat140
(chr17:92,342,663) and the telomere [35]. We identified
a total of 151,981 SNVs and 28,870 INDELs. After sub-
tracting the known variants registered in dbSNP (Build
138; April 25, 2013), 46,737 SNVs and 28,378 INDELs
remained. These variants were further filtered using in-
formation from the linkage analysis, yielding a final total
of two SNVs and two INDELs. One of these was a non-
synonymous variant in the CDS of Edaradd. By evaluating
the functional protein-level consequences of these muta-
tions using the PolyPhen-2 program [37], the C to T tran-
sition mutation in the last exon of Edaradd (Fig. 4), which
changes proline to serine at codon 153 of the EDARADD
protein, was predicted to be a damaging mutation. Indeed,
this mutation was previously identified as causative for the
HED phenotype [35].
Next, we sought to validate whether this method could
successfully detect the causative mutation for cataract
development in the KFRS4/Kyo strain [28]. By linkage
analysis, the mutation responsible for the cataract pheno-
type was mapped to an interval of 9.7 Mb on chromosome
7 [28], which contains about 150 genes. We identified
134,604 SNVs and 25,578 INDELs in the KFRS4/Kyo strain.
The numbers of variants were reduced to 49,747 SNVs and
25,190 INDELs after filtering out known variants. Among
these, 234 SNVs and 72 INDELs were located in the 9.7-
Mb interval identified by the linkage analysis. Mip, one of
the genes in this region, has previously been identified as a
causative gene because of its known role in cataracts in
humans and mice [38, 39], and an observed 5-bp insertion
in KFRS4/Kyo was predicted to have a severe effect on the
protein product [28]. Among the 72 INDELs identified by
the TargetEC reads obtained for KFRS4/Kyo, we also ob-
served the same 5-bp insertion in exon 1 of Mip (Fig. 5a),
indicating that the TargetEC method can detect the causa-
tive mutation for cataract formation in KFRS4/Kyo.
The KFRS4/Kyo strain also exhibits other phenotypes
[40]. One such phenotype is congenital ear malformation,
also known as the “dumbo” phenotype [40]. Although the
responsible locus was mapped to a 6-Mb interval on
chromosome 14, which contains the Hmx1 gene, no cod-
ing changes were identified in this region [40]; eventually,
deletion of a conserved regulatory element for Hmx1, lo-
cated approximately 80-kb downstream of the gene, was
identified [29]. Here, we applied the MACS2 program,
which is usually used for peak calling in ChIP-seq experi-
ments, to the mapped reads of KFRS4/Kyo and the con-
trol strain PVG/Seac in order to systematically identify
large deletions as differences in the accumulated reads.
We identified 6554 peak regions specific for PVG/Seac,
which were hence thought to be KFRS4/Kyo-specific dele-
tions. Of these peaks, 15 were located within the 6.0-Mb
interval on chromosome 14; the most significant, accord-
ing to the ratio of read numbers, was the deletion located
approximately 80-kb downstream of Hmx1 (Fig. 5b),
which exactly corresponds to the deletion identified in the
conserved regulatory element for Hmx1 [29].
Discussion
In this paper, we designed a novel target capture probe
set, TargetEC, for rat genome analysis. This probe set not
only covers exons for all annotated genes but also covers
regions that are highly conserved across vertebrate spe-
cies. Although the span of covered regions (146.8 Mb) is
approximately three times larger than that covered by
conventional human (58.0 Mb; Agilent Human All Exon
V6) and mouse (49.6 Mb; Agilent Mouse All Exon) exome
probes, it can potentially identify regulatory mutations
that cannot be detected using conventional exome strat-
egies. Another advantage associated with the inclusion of
conserved regions is that most genic regions will be cov-
ered even without explicitly using gene annotation infor-
mation. This can be a great advantage, especially for





Fig. 4 Validation of the causative mutation for HED in the WTC-swh/Kyo strain. A C-to-T transition mutation, which was previously confirmed as a
causative mutation for HED [35], was identified in the Edaradd gene. The locus is compared with that of the normal strain (WTC/Kyo)
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Regarding variants identified in coding regions, predic-
tions of functional consequences are rather straightfor-
ward because several types of mutations, including
synonymous, non-synonymous, inframe stop, and frame-
shift mutations exist, and each has different effects on
the protein products. Indeed, several existing programs
can classify these types of mutations [41] and predict the
severity of the mutant phenotypes [37, 42, 43]. On the
other hand, predicting the effects of variations in non-
coding regions might not be an easy task. This might
explain why non-coding regions have not been previously
analyzed using conventional target capture methods
(i.e., exome analysis), although a certain fraction of
disease-associated mutations are known to be located
in non-coding regions (for review, see [15–18]). In this
study, we included both CNSs and exons as capture tar-
gets. These CNSs may be plausible targets for regulatory
mutations because of the high conservation among verte-
brate species, which implies the action of strong negative
selection on these sites. Validation of the ability of our
target capture kit to detect mutations in the regulatory
element of Hmx1 suggests that this kit can be a powerful
tool for the detection of regulatory mutations, which are
not currently well annotated in genome databases. To
evaluate the functional relevance of CNS mutations in the
rat, we can incorporate information about epigenomic
states [44, 45] such as H3K4me1, the histone modification
associated with enhancers in the human and mouse, by
transferring this information to corresponding regions in
the rat genome [46]. Given the number and the total
length of CNSs, huge amounts of regulatory mutations
might be responsible for certain phenotypes because
mutations in non-coding regions only alter the spatio-
temporal expression of target genes while maintaining
the function of the protein products. On the other
hand, critical mutations in coding regions completely
change the functions of protein products, which might
lead to severe or often lethal phenotypes.
In conventional exome analysis, information about













Fig. 5 Validation of mutations in the KFRS4/Kyo strain. Each locus is compared with the corresponding locus in the closely related strain PVG/Seac.
a The causative mutation for cataracts. A 5-bp insertion, which was previously reported as the causative mutation for cataracts in KFRS4/Kyo [28], was
identified near the end of exon 1 of the Mip gene. b Deletion of a CNS responsible for congenital ear malformation in KFRS4/Kyo. This deletion, which
was previously identified as the mutation responsible for congenital ear malformation [29], was located approximately 80-kb downstream of
the Hmx1 gene
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mutations. In humans, the number of SNPs registered in
dbSNP has increased rapidly, and continues to increase
further as a result of progress in genome sequencing
projects for individuals such as the 1000 Genomes Pro-
ject [47]. On the other hand, the number of SNPs identi-
fied in rat is far less than those in the human and
mouse. However, recent continuous and steady progress
has been made in the field of rat genome resequencing
[23–26]. The genome resequencing of closely-related
reference strains has yielded massive and valuable infor-
mation about genetic variations in the rat. Exome se-
quencing of many sample strains represents another
possible approach to overcoming this shortfall of infor-
mation about genetic variations in the rat. In fact, this
strategy was adopted in the pilot phase of the 1000 Ge-
nomes Project, where more than half of the samples
were subjected to exome sequencing to reveal rare varia-
tions in a cost-effective manner [48]. Following this
strategy, the application of TargetEC to a large stock of
mutant strains, such as that stored by NBRP-Rat in
Japan [32], would be useful for the collection of common
and rare variations in functionally important regions and
would therefore facilitate the identification of mutations
responsible for certain phenotypes in mutant strains. This
type of analysis is our future aim. The data obtained dur-
ing this analytical course would be disclosed to public re-
positories, and would thus be of potential value to the rat
genetics and genomics research communities.
One of the drawbacks for TargetEC is that the total
length of the covered regions is approximately three-fold
greater than that achieved with a conventional exome
kit (e.g., a widely used human exome capture kit). Al-
though a three-fold higher number of reads is needed to
obtain the same depth of coverage as those obtained by
conventional exome sequencing, the total length of the
target regions remains 20-fold less than the entire gen-
ome, thus confirming the feasibility of this strategy rela-
tive to whole genome sequencing (WGS) when seeking
relevant mutations for certain phenotypes. Moreover,
rapid growth in sequencer performance will render the
TargetEC strategy an even more affordable option for the
detection of variations not only in exonic regions, but also
in functionally important CNSs.
To experimentally confirm the involvement of a candi-
date mutation identified by target capture sequencing,
we can use a gene knockout procedure that was recently
established for rats. An early N-ethyl-N-nitrosourea (ENU)
mutagenesis-based method was devised for knockout rat
generation [49, 50]. With the recent emergence of genome
editing technology, it is more feasible to implement gen-
omic modifications in rats to analyze the phenotypic effects
of genes [51, 52]. In these circumstances, TargetEC can be
applied to laboratory rats that exhibit various disease phe-
notypes; the resulting experimental confirmation of the
involvement of the identified mutations would shed
light on the genetic cause underlying these mutants and
promote mechanistic insights into the disease etiology.
This design strategy (i.e., targeting both exonic regions
and CNSs) can easily be applied to human samples for
the detection of regulatory mutations associated with
certain phenotypes. Moreover, TargetEC developed in this
study might have a potential to be directly applied to
cross-species capture [11], for example, for other rodents,
because it covers all the regions that are highly conserved
(phastCons score = 1.0) among vertebrates, although we
need further evaluation of experimental conditions and
performance for such purpose [53].
Conclusions
The target capture design reported herein can potentially
be used to identify additional mutations responsible for
various phenotypes in the rat, which is a suitable model
organism for comparative studies of diseases and other
traits. The potential mutations include not only those in
coding regions but also those in CNSs, which might cor-
respond to regulatory mutations. By further analyzing
these mutations, we will deepen our understanding of the
relationships between the genotypic and phenotypic varia-
tions associated with regulatory elements.
Methods
Animals
WTC/Kyo (NBRP Rat No. 0020), WTC-swh/Kyo (NBRP
Rat No. 0287), PVG/Seac (NBRP Rat No. 0080), and
KFRS4/Kyo (NBRP Rat No. 0572) rats were provided by the
Japanese NBRP-Rat [32]; http://www.anim.med.kyoto-u.
ac.jp/nbr/) and maintained at the Institute of Laboratory
Animals, Graduate School of Medicine, Kyoto University,
under a specific pathogen-free environment. All animal ex-
perimentation protocols were approved by the Institutional
Animal Care and Use Committees of Kyoto University and
were conducted according to the Regulation on Animal
Experimentation at Kyoto University.
Genome annotation data used to design the target
regions for TargetEC
The rat genome assembly rn5 (RGSC 5.0, March 2012)
was used as a reference genome in this study. We used
gene annotations from RefSeq [30] and Ensembl [31] for
the rat (rn5); these were downloaded from the Table
Browser function in the UCSC Genome Browser [54]. We
also used highly conserved regions (phastCons score = 1.0)
[21] among 13 vertebrate species (multiz alignment of 13
vertebrates), which were also downloaded from the UCSC
Genome Browser [55]. We merged all of these regions
(i.e., those annotated in RefSeq and/or Ensembl and the
conserved regions) using the “merge” option in the
BEDTools program [56]. Regions <100 bp in length
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were expanded in both directions to reach a minimum
length of 100 bp. After these expansions, overlapping
regions were further unified using the “merge” option
in the BEDTools program. Based on the obtained target
regions, a probe set for sequence capture (SeqCap EZ
Developer Library; Roche NimbleGen, Madison, WI,
USA) was designed and synthesized according to the
manufacturer’s internal protocols.
Sample preparation and sequencing
Target capture was performed using the standard SeqCap
EZ System protocol (Roche NimbleGen). DNA sequen-
cing libraries were prepared using the KAPA HyperPlus
Library Preparation Kit (KAPA Biosystems, London, UK)
according to the manufacturer’s protocol. We applied two
samples for one-reaction reagents. Sequencing was per-
formed on an Illumina HiSeq 1500 (Illumina, San Diego,
CA, USA) in Rapid Run mode PE250 (v2) (WTC/Kyo and
WTC-swh/Kyo) and Rapid Run mode PE100 (v1) (PVG/
Seac and KFRS4/Kyo), according to the manufacturer’s
protocol.
Quality control of the sequencing reads
The reads generated using the Illumina HiSeq platform
were subjected to quality control to exclude low quality
reads. Initially, we used the FastQC program (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/) to
evaluate the overall read quality. Next, we trimmed reads
from the 3’-end to address low quality bases (quality
score of <30). After this trimming step, shortened reads
(length of <30) were discarded from further analysis.
Read mapping and variant identification
We followed a previously reported basic exome data
analysis procedure [57]. In brief, the reads that passed the
above quality control were first mapped onto the reference
rat genome (rn5; RGSC 5.0, March 2012) using BWA
(v0.7.4) [58] with the default parameters. SAMtools
(v0.1.12a) [59] was used for file format conversion and
indexing. For post-processing of this mapping step, dupli-
cated reads were removed based on mapping position of
the mates using the MarkDuplicates program in Picard
tools (v1.87) (http://broadinstitute.github.io/picard/).
Next, the RealignerTargetCreator and IndelRealigner
utilities in the Genome Analysis Toolkit (GATK; v3.6)
[60] and the FixMateInformation utility in Picard tools
were used to realign the reads. To calculate basic sta-
tistics, we considered a read to be on target if the read
overlap a target region by at least 1 bp. Quality score
recalibration was conducted with the BaseRecalibrator
utility in the GATK, using known SNVs and small
INDELs collected from dbSNP (Build 138; April 25, 2013).
The same known variant set was used for filtering to nar-
row down the number of candidate mutations associated
with the phenotypes. Variant calling was performed using
the HaplotypeCaller utility in the GATK.
Variant annotation
BEDTools (v2.17.0) [56] was used to filter out known
variants from those identified in a sample. ANNOVAR
(version 22-March-2015) [41] was used for the functional
annotation of variants, with RefSeq genes and Ensembl
genes used as the rat gene annotations. PolyPhen-2 was
used to assess the functional consequences of mutations
[37]. The Integrative Genome Viewer (IGV; v2_2_13) [61]
was used to visualize the mapped reads and variants.
Detection of large deletions
The BAM files obtained from the read mapping were used
to detect large deletions. For this procedure, we applied
the peak calling program, MACS2 [62], to the BAM file
for the mutant strain and its control strain. By comparing
the peak regions in the mutant and control strains
using the Subtract option in BEDTools [56], we defined
a deletion in the mutant strain if there is a peak only in
the control strain. Then the identified peaks were visu-
ally inspected by using IGV (v2_2_13) [61].
Additional file
Additional file 1: Table S1. Summary statistics for SNV and INDEL in
various depths. Figure S1. Sequence coverage of the target regions for
each rat strain. Figure S2. Number of homozygous SNVs identified in
WTC/Kyo and PVG/Seac strains for each genomic region. Figure S3.
Proportion of the number of SNVs in terms of the each class of regions
in the target, i.e., CDS, UTR, CNS, and other regions, for each rat strain.
Figure S4. The relationship between the phastCons conservation score
and SNV density for each rat strain. (PDF 215 kb)
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